01

SPI Pharma

U.S.A

World Vaccine Congress

Attending

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Granule / Pellet, Tablet

Grade : Oral

Brand Name : Mannogem Powder

Application : Fillers, Diluents & Binders, Granulation, Solubilizers

Excipient Details : Mannogem (mannitol powder) is an excellent excipient for use in wet granulation, lyophilization & improves solubility of poorly soluble APIs.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Mannitol

Dosage Form : Granule / Pellet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Mannitol

Dosage Form : Granule / Pellet, Tablet

Category : Fillers, Diluents & Binders, Granulation, Solubilizers

Brand : MANNOGEM POWDER

Applications : Mannogem (mannitol powder) is an excellent excipient for use in wet granulation, lyophilization & improves solubility of poorly soluble APIs.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

02

Evonik

Germany

CPhI WW Frankfurt

Booth #5.1A24

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : EUDRAGIT® FS 30 D

Application : Solubilizers

Excipient Details : EUDRAGIT® FS 30 D (aqueous dispersion), a delayed release polymer, used to increase solubility of poorly soluble OSDs such as tablets and capsules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid Excipient, Methyl Acrylate, Methyl Methacrylate

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid Excipient, Methyl Acrylate, Methyl Methacrylate

Dosage Form : Capsule, Tablet

Category : Solubilizers

Brand : EUDRAGIT® FS 30 D

Applications : EUDRAGIT® FS 30 D (aqueous dispersion), a delayed release polymer, used to increase solubility of poorly soluble OSDs such as tablets and capsules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

03

Nanjing Well Pharmaceutical

China

CPhI WW Frankfurt

Booth #12.1G60

Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet

Grade : Parenteral, Oral, Topical

Brand Name : Polysorbate 80

Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.

Pharmacopoeia Ref : ChP/USP/EP/JP

Technical Specs : NA

Ingredient(s) : Polysorbate 80

Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet

Grade : Parenteral, Oral, Topical

Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Ingredient(s) : Polysorbate 80

Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet

Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

Brand : POLYSORBATE 80

Applications : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.

Pharmacopoeia Ref : ChP/USP/EP/JP

Technical Specs : NA

Grade : Parenteral, Oral, Topical

04

Kirsch Pharma

Germany

CPhI WW Frankfurt

Booth #8.0Q24

High-quality raw materials and custom blends for pharma, biopharma, nutrition, veterinary, and cosmetics worldwide.

Dosage Form : Injectable / Parenteral

Grade : Biopharma Grade

Brand Name : Poloxamer 188

Application : Parenteral, Surfactant & Foaming Agents

Excipient Details : Used as surfactant agent in cell culture media, in protein purification and in injectable formulations.

Pharmacopoeia Ref : On Request

Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)

Ingredient(s) : Poloxamer 188

Dosage Form : Injectable / Parenteral

Grade : Biopharma Grade

High-quality raw materials and custom blends for pharma, biopharma, nutrition, veterinary, and cosmetics worldwide.

Ingredient(s) : Poloxamer 188

Dosage Form : Injectable / Parenteral

Category : Parenteral, Surfactant & Foaming Agents

Brand : POLOXAMER 188

Applications : Used as surfactant agent in cell culture media, in protein purification and in injectable formulations.

Pharmacopoeia Ref : On Request

Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)

Grade : Biopharma Grade

05

Nanjing Well Pharmaceutical

China

CPhI WW Frankfurt

Booth #12.1G60

Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Dosage Form : Capsule, Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Solution, Suspension, Tablet

Grade : Parenteral, Oral, Topical

Brand Name : Poloxamer 188

Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Thickeners and Stabilizers, Topical

Excipient Details : Poloxamer 188 is used as a solubilizer, emulsifier, stabilizer in parenteral, OSDs & topical formulations such as creams, gels & lotions.

Pharmacopoeia Ref : ChP/USP/EP

Technical Specs : Oxyethylene unit: 75%-85%, Oxypropylene unit: 25%-30%

Ingredient(s) : Poloxamer 188

Dosage Form : Capsule, Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Solution, Suspension, Tablet

Grade : Parenteral, Oral, Topical

Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Ingredient(s) : Poloxamer 188

Dosage Form : Capsule, Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Solution, Suspension, Tablet

Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Thickeners and Stabilizers, Topical

Brand : POLOXAMER 188

Applications : Poloxamer 188 is used as a solubilizer, emulsifier, stabilizer in parenteral, OSDs & topical formulations such as creams, gels & lotions.

Pharmacopoeia Ref : ChP/USP/EP

Technical Specs : Oxyethylene unit: 75%-85%, Oxypropylene unit: 25%-30%

Grade : Parenteral, Oral, Topical

06

Evonik

Germany

CPhI WW Frankfurt

Booth #5.1A24

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : EUDRAGIT® L 100

Application : Controlled & Modified Release, Solubilizers

Excipient Details : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer

Dosage Form : Capsule, Tablet

Category : Controlled & Modified Release, Solubilizers

Brand : EUDRAGIT® L 100

Applications : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

07

Evonik

Germany

CPhI WW Frankfurt

Booth #5.1A24

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Brand Name : EUDRAGIT® L 100-55

Application : Coating Systems & Additives, Controlled & Modified Release, Solubilizers

Excipient Details : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

Dosage Form : Capsule, Granule / Pellet, Tablet

Category : Coating Systems & Additives, Controlled & Modified Release, Solubilizers

Brand : EUDRAGIT® L 100-55

Applications : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

08

Evonik

Germany

CPhI WW Frankfurt

Booth #5.1A24

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : EUDRAGIT® L 12,5

Application : Solubilizers

Excipient Details : EUDRAGIT® L 12,5 (organic solution), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets and capsules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer

Dosage Form : Capsule, Tablet

Category : Solubilizers

Brand : EUDRAGIT® L 12,5

Applications : EUDRAGIT® L 12,5 (organic solution), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets and capsules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

09

Evonik

Germany

CPhI WW Frankfurt

Booth #5.1A24

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : EUDRAGIT® S 12,5

Application : Solubilizers

Excipient Details : EUDRAGIT® S 12,5 (Organic solution) a delayed release polymer, used to increase solubility of poorly soluble drugs such as tablets and capsules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer

Dosage Form : Capsule, Tablet

Category : Solubilizers

Brand : EUDRAGIT® S 12,5

Applications : EUDRAGIT® S 12,5 (Organic solution) a delayed release polymer, used to increase solubility of poorly soluble drugs such as tablets and capsules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

10

CD Formulation

GLYCERYL MONOSTEARATE

Aus. Peptide Conference

Not Confirmed

Looking for Esomeprazole? Find Solubilizers used in Esomeprazole to address drug delivery challenges on PharmaCompass.

Esomeprazole

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

194 API Suppliers

65 USDMF

48 CEP/COS

7 JDMF

50 EU WC

68 KDMF

46 NDC API

65 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

32 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

862 FDF Dossiers

105 FDA Orange Book

317 Europe

23 Canada

145 Australia

68 South Africa

204 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED RELEASE;ORAL - EQ 20MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 40MG BASE

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

7 Evonik

1 Rochem International Inc

18 SPI Pharma

10 DKSH

3 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

4 Kirsch Pharma

4 ACG Worldwide

6 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

30 BASF

2 CD Formulation

15 Corel Pharma Chem

3 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

2 Finar

11 Gangwal Chemicals

12 Ideal Cures

4 Ingredion Pharma Solutions

11 Kerry

2 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

11 Microlex e.U

2 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons